Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 5c; Trims FY12 EPS Range
Get Alerts EW Hot Sheet
Price: $88.40 +0.12%
EPS Growth %: +10.4%
Financial Fact:
Net sales: 739.4M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +10.4%
Financial Fact:
Net sales: 739.4M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $459.2 million versus the consensus estimate of $449.75 million.
Edwards Lifesciences Corp. sees FY2012 EPS of $2.58-$2.68, versus prior guidance of $2.70-$2.80 and the consensus of $2.67.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Edwards Lifesciences Corp. sees FY2012 EPS of $2.58-$2.68, versus prior guidance of $2.70-$2.80 and the consensus of $2.67.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Oak Valley Bancorp (OVLY) Tops Q3 EPS by 77c
- Kaiser Aluminum (KALU) Misses Q3 EPS by 48c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share